Closed for Enrollment

• A High Throughput and Multiplex Platform for Engineering TCR-Tregs for ALS Therapy Scottsdale/Phoenix, AZ

  The purpose of this study is to develop disease-specific Tregs that target specifically antigens involved in ALS pathogenesis and they harbor a lower risk of general immunosuppression.